Category : Search result: epilepsy treatment India


AIIMS Delhi Starts Free Epilepsy Drug Monitoring

AIIMS New Delhi now provides free Therapeutic Drug Monitoring for epilepsy patients, saving costs up to ₹1,880 per test. This move aims to improve treatment outcomes and adherence. Read more.

Noida's Phased Plan to Treat Wastewater, Clean Yamuna

Noida Authority greenlights a multi-phase project to intercept and treat sewage from city drains flowing into the Yamuna. The plan, mandated by NGT, includes new STPs and bioremediation, with completion targeted for 2028. Read the full story.

Man dies in bonfire during epileptic seizure in UP

A 35-year-old man from Uttar Pradesh tragically died after falling into a bonfire during an epileptic seizure. The incident highlights the dangers faced by individuals with neurological conditions.

HIV Treatment Dropouts Rise in India, Data Shows

New NACO data reveals a worrying rise in HIV patients dropping out of treatment in India, with over 20,000 lost in 2024-25. Experts call for urgent action to retain patients in care programs.

DBS Surgery in Noida Cures Turkmen Man's Severe Tremors

A 65-year-old from Turkmenistan regained motor control after Deep Brain Stimulation surgery at Medanta Noida. The procedure ended his years-long battle with debilitating hand tremors. Read his inspiring recovery story.

6 Daily Routines for Better Dementia Care

Discover how structured daily routines can reduce agitation and improve emotional stability for dementia patients. Expert tips from Indian neurologists and care specialists.

Eye changes predict leukemia treatment response: Study

Hyderabad study reveals eye changes in leukemia patients can predict treatment success. Regular eye tests emerge as crucial diagnostic tool for cancer monitoring. Learn how vision symptoms indicate disease progression.

BBCI Celebrates 52nd Foundation Day in Guwahati

Dr B Borooah Cancer Institute commemorates over five decades of pioneering cancer treatment and research. Governor Acharya highlights national collaborations and future medical advancements.

Alzheimer's Drug Donanemab Approved in India

Eli Lilly's Alzheimer's drug donanemab gets Indian regulatory approval. The treatment slows cognitive decline by 35.1% and could be available next year. Learn about its benefits and pricing.

Alzheimer's Drug Donanemab Approved for India

Eli Lilly's Alzheimer's drug donanemab gets Indian regulator nod. The treatment slows cognitive decline by 35.1% and is expected to launch in India next year. Details on pricing and safety.

Page 1 of 4